RiverGlades Family Offices LLC Cuts Stake in CME Group Inc. $CME

RiverGlades Family Offices LLC lowered its stake in shares of CME Group Inc. (NASDAQ:CME) by 52.9% in the second quarter, Holdings Channel reports. The firm owned 800 shares of the financial services provider’s stock after selling 900 shares during the period. RiverGlades Family Offices LLC’s holdings in CME Group were worth $220,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. OMNI 360 Wealth Inc. acquired a new position in shares of CME Group in the 1st quarter worth approximately $367,000. Fulcrum Equity Management acquired a new position in shares of CME Group in the 1st quarter worth approximately $258,000. AIA Group Ltd lifted its holdings in shares of CME Group by 17.8% in the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock worth $4,416,000 after acquiring an additional 2,510 shares during the last quarter. 49 Wealth Management LLC acquired a new position in shares of CME Group in the 1st quarter worth approximately $602,000. Finally, Lockheed Martin Investment Management Co. lifted its holdings in shares of CME Group by 34.1% in the 1st quarter. Lockheed Martin Investment Management Co. now owns 58,690 shares of the financial services provider’s stock worth $15,570,000 after acquiring an additional 14,910 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Activity

In other news, insider Timothy Francis Mccourt sold 379 shares of the company’s stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the transaction, the insider owned 9,508 shares in the company, valued at approximately $2,470,463.64. This represents a 3.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, General Counsel Jonathan L. Marcus sold 392 shares of the stock in a transaction dated Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the transaction, the general counsel owned 7,851 shares of the company’s stock, valued at $2,056,962. This represents a 4.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 13,043 shares of company stock worth $3,527,956 over the last ninety days. Insiders own 0.30% of the company’s stock.

CME Group Price Performance

CME Group stock opened at $264.16 on Tuesday. CME Group Inc. has a 12-month low of $213.94 and a 12-month high of $290.79. The stock has a market capitalization of $95.26 billion, a P/E ratio of 25.60, a P/E/G ratio of 4.41 and a beta of 0.41. The firm’s 50-day moving average is $265.69 and its two-hundred day moving average is $272.18. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.63 by $0.05. The business had revenue of $1.54 billion for the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The company’s quarterly revenue was down 3.0% on a year-over-year basis. During the same period last year, the company earned $2.68 earnings per share. Equities analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were paid a dividend of $1.25 per share. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group’s payout ratio is presently 48.45%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on CME shares. Wall Street Zen lowered shares of CME Group from a “hold” rating to a “sell” rating in a report on Sunday, July 13th. The Goldman Sachs Group increased their price objective on shares of CME Group from $262.00 to $263.00 and gave the company a “sell” rating in a research report on Thursday, October 23rd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of CME Group in a research report on Wednesday, October 8th. Raymond James Financial decreased their price target on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a research note on Monday, October 13th. Finally, JPMorgan Chase & Co. increased their price target on shares of CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research note on Tuesday, October 14th. Eight investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, CME Group has a consensus rating of “Hold” and a consensus price target of $285.19.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.